[Primary and secondary prevention in hypercholesterolemia: differences relevant to patient care in the PROCYON trial].

ABSTRACT:

Background

Cardiovascular disease accounts for one third of deaths in Germany. Elevated levels of low-density lipoprotein cholesterol (LDL-C) are considered a major risk factor. Lowering LDL-C levels is therefore an integral part of the prevention of cardiovascular events.

Methods

The aim of this work is to identify potential differences between primary prevention (PP) and secondary prevention (SP) by means of a post-hoc comparison of cross-sectional data from the PROCYON survey. Medical history, concomitant diseases, adherence, and disease awareness in relation to hypercholesterolemia were queried.

Results

5,494 patients had participated in the survey (PP: 3,798; SP: 1,696). Comparison of the results showed a numerically higher proportion of women (PP 70.7% vs. SP 42

SUBMITTER: Makhmudova U 

PROVIDER: S-EPMC10946085 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature